Page last updated: 2024-08-22

angiotensin ii and as 605240

angiotensin ii has been researched along with as 605240 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, L; Feng, Y; Gan, H; Haydon, RC; He, TC; Huang, B; Huang, S; Lei, J; Liu, W; Luo, W; Luu, HH; Shu, Y; Wang, X; Xia, Y; Yan, S; Yu, X; Yuan, C; Zeng, L; Zeng, Z; Zhang, B; Zhang, H; Zhang, L; Zhang, R; Zhang, X; Zhao, C	1

Other Studies

1 other study(ies) available for angiotensin ii and as 605240

Article	Year
A blockade of PI3Kγ signaling effectively mitigates angiotensin II-induced renal injury and fibrosis in a mouse model. Scientific reports, 2018, Jul-20, Volume: 8, Issue:1 Topics: Angiotensin II; Animals; Cell Proliferation; Class Ib Phosphatidylinositol 3-Kinase; Cytokines; Disease Models, Animal; Fibroblasts; Fibrosis; Kidney; Mice; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Quinoxalines; Renal Insufficiency, Chronic; Thiazolidinediones	2018

Article

Year

A blockade of PI3Kγ signaling effectively mitigates angiotensin II-induced renal injury and fibrosis in a mouse model.

Scientific reports, 2018, Jul-20, Volume: 8, Issue:1

Topics: Angiotensin II; Animals; Cell Proliferation; Class Ib Phosphatidylinositol 3-Kinase; Cytokines; Disease Models, Animal; Fibroblasts; Fibrosis; Kidney; Mice; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Quinoxalines; Renal Insufficiency, Chronic; Thiazolidinediones

2018